Back
EverQuote Vs. Kymera Therapeutics Industry Stock Comparison
Buy
78
EVER
EverQuote
Last Price:
$25.35
Seasonality Move:
-9.78%
Buy
58
KYMR
Kymera Therapeutics
Last Price:
$44.97
Seasonality Move:
5.78%
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $45.18. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EVER Stock Price Chart
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $45.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
EVER Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.5 | Buy |
Relative Strength Index (14 RSI): | 56.06 | Buy |
Chaikin Money Flow: | 123515 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.95 - 25.29) | Buy |
Bollinger Bands (100): | (22.27 - 26.41) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.28 | Buy |
Relative Strength Index (14 RSI): | 58.65 | Buy |
Chaikin Money Flow: | 148937 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.31 - 47.41) | Sell |
Bollinger Bands (100): | (27.26 - 42.14) | Buy |
EVER Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.46 | Buy |
20-day SMA: | 24.56 | Buy |
50-day SMA: | 24.26 | Buy |
200-day SMA: | 21.86 | Buy |
8-day EMA: | 9.77 | Buy |
20-day EMA: | 4.48 | Buy |
50-day EMA: | 1.9 | Buy |
200-day EMA: | 0.49 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.24 | Buy |
20-day SMA: | 45.81 | Sell |
50-day SMA: | 38.7 | Buy |
200-day SMA: | 39.53 | Buy |
8-day EMA: | 17.55 | Buy |
20-day EMA: | 8.05 | Buy |
50-day EMA: | 3.41 | Buy |
200-day EMA: | 0.88 | Buy |
EverQuote Earnings Growth & EVER Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.24 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.
EverQuote Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |